Follow-up of infants given measles vaccine at 6 months of age: Antibody and CMI responses to MMRII® at 15 months of age and antibody levels at 27 months of age

Vaccine

Volumn 23, Issue 25, 2005, Pages 3247-3255

  Carson, Mary M ^a,c   Spady, Donald W ^a   Beeler, Judith A ^b   Krezolek, Margaret P ^a   Audet, Susette ^b   Pabst, Henry F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Capital Health Edmonton   (Canada)

Author keywords

Immune response; Measles vaccines; Vaccination regime

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MMRII; PENTA;

ANTIBODY BLOOD LEVEL; ARTICLE; BLAST TRANSFORMATION; CELLULAR IMMUNITY; DEVELOPING COUNTRY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNIZATION; INFANT; INNATE IMMUNITY; LYMPHOCYTE; MEASLES; MEASLES VACCINATION; PRIORITY JOURNAL; VACCINATION; VIRUS CULTURE;

EID: 17144393744     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.092     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention Summary of notifiable diseases - United States, 2001 MMWR 50 2003 1 108
2. Pan American Health Organization. Measles surveillance in the Americas. Final measles surveillance data, 2001. Available from URL: http://www.paho.org/ English/hvp/hvi/hvp_efinclas_2001.pdf.
3. Centers for Disease Control Interstate importation of measles following transmission in an airport - California, Washington, 1982 MMWR 32 1983 215 216
4. R.A. Weinstein Planning for epidemics - the lessons of SARS N Engl J Med 350 2004 2333 2334
5. H.F. Pabst, D.W. Spady, R.G. Marusyk, M.M. Carson, L.W. Chui, and M.R. Joffres Reduced measles immunity in infants in a well-vaccinated population Pediatr Infect Dis J 11 1992 525 529
6. M. Papania, A.L. Baughman, S. Lee, J.E. Cheek, W. Atkinson, and S.C. Redd Increased susceptibility to measles in infants in the United States Pediatrics 104 1999 e59 Available from URL: http://pediatrics.aappublications.org/cgi/ reprint/104/5/e59.pdf
7. Centers for Disease Control and Prevention. The yellow book. health information for international travel, 2003-2004. Available from URL: http://www.cdc.gov/travel/child-vax.htm.
8. American Academy of Pediatrics. 2003 Red Book®. Elk Grove Village: American Academy of Pediatrics; 2003.
9. Health Canada. Measles in Canada. Measles update 1997;5. Available from URL: http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/meas-roug/1997/mesl5-2_e. html#measles.
10. Centers for Disease Control and Prevention Measles outbreak - Netherlands, April 1999-January 2000 MMWR 49 2000 299 303
11. Centers for Disease Control and Prevention Measles outbreak associated with an imported case in an infant - Alabama, 2002 MMWR 53 2004 30 33
12. Centers for Disease Control and Prevention Epidemiology of measles - United States, 2001-2003 MMWR 53 2004 713 716
13. M.M. Carson, D.W. Spady, P. Albrecht, J.A. Beeler, J. Thipphawong, and L. Barreto Measles vaccination of infants in a well-vaccinated population Pediatr Infect Dis J 14 1995 17 22
14. H.F. Pabst, D.W. Spady, M.M. Carson, M.P. Krezolek, L. Baretto, and R.C. Wittes Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6-month-old infants Vaccine 17 1999 1910 1918
15. H.F. Pabst, P.M. Boothe, and M.M. Carson A comparison of alternate immunization regimes for measles in vaccinated populations Vaccine 17 1999 182 192
16. J.S. Gindler, W.L. Atkinson, L.E. Markowitz, and S.S. Hutchins Epidemiology of measles in the United States in 1989 and 1990 Pediatr Infect Dis J 11 1992 841 846
17. O. Tidjani, B. Grunitsky, N. Guerin, D. Levy-Brahl, N. Lecam, and C. Zukereff Serological effects of Edmonston-Zagreb, Schwarz and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months Lancet 2 1989 1357 1360
18. V.M. Bolotovski, M. Grabowsky, C.J. Clements, P. Albrecht, E.R. Brenner, and A.I. Zargaryantzs Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine Int J Epidemiol 23 1994 1069 1077
19. F.T. Cutts, M. Grabowsky, and L.E. Markowitz The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants Biologicals 23 1995 95 106
20. R.G. Mathias, W.G. Meekison, T.A. Arcand, and M.T. Schechter The role of secondary vaccine failures in measles outbreaks Am J Public Health 79 1989 475 478
21. P.M. Strebel, M.J. Papania, and N.A. Halsey Measles vaccines S.A. Plotkin W.A. Orenstein Vaccines 2004 Elsevier Inc. Philadelphia 399 440
22. Health Canada. Epidemiology of a measles outbreak in Alberta, 1997. Measles update 1997;5 Available from URL: http://www.hc-sc.gc.ca/pphb-dgspsp/ publicat/meas-roug/1997/mesl5-2_e.html.
23. Centers for Disease Control and Prevention Recommended childhood immunization schedule - United States, 1997 MMWR 46 1997 35 40
24. P. Albrecht, K. Herrmann, and G.R. Burns Role of virus strain in conventional and enhanced measles plaque neutralization test J Virol Methods 3 1981 251 260
25. R.T. Chen, L.E. Markowitz, P. Albrecht, J.A. Stewart, L.M. Mofenson, and S.R. Preblud Measles antibody: reevaluation of protective titers J Infect Dis 162 1990 1036 1042
26. D.E. Griffin, and B.J. Ward Differential CD4 T cell activation in measles J Infect Dis 168 1993 275 281
27. H.A. Gans, Y. Maldonado, L.L. Yasukawa, J. Beeler, S. Audet, and M.M. Rinki IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants J Immunol 162 1999 5569 5575
28. H. Gans, R. DeHovitz, B. Forghani, J. Beeler, Y. Maldonado, and A.M. Arvin Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life Vaccine 21 2003 3398 3405
29. H.A. Gans, L.L. Yasukawa, A. Alderson, M. Rinki, R. DeHovitz, and J. Beeler Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States J Infect Dis 190 2004 83 90
30. R.M. Zinkernagel, and H. Hengartner Regulation of the immune response by antigen Sci 293 2001 251 253
31. G.A. Poland, I.G. Ovsyannikova, R.M. Jacobson, R.A. Vierkant, S.J. Jacobsen, and V.S. Pankratz Identification of an association between HLA class II alleles and low antibody levels after measles immunization Vaccine 20 2001 430 438
32. M.S. Lee, D.J. Nokes, H.M. Hsu, and C.F. Lu Protective titres of measles neutralising antibody J Med Virol 62 2000 511 517
33. R.A. Good, and S.J. Zak Disturbances in gamma globulin synthesis as "experiments of nature" Pediatrics 18 1956 109 149
34. A.B. Sabin, A. Flores Arechiga, J. Fernandez de Castro, P. Albrecht, J.L. Sever, and I. Shekarchi Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response J Am Med Assoc 251 1984 2363 2371
35. H.F. Pabst, and H.W. Kreth Ontogeny of the immune response as a basis of childhood disease J Pediatr 97 1980 519 534
36. C. Miller, C.P. Farrington, and K. Harbert The epidemiology of subacute sclerosing panencephalitis in England and Wales Int J Epidemiol 21 1992 998 1006
37. S.S. Hutchins, A. Dezayas, K. Le Blond, J. Heath, W. Bellini, and S. Audet Evaluation of an early two-dose measles vaccination schedule Am J Epidemiol 154 2001 1064 1071
38. C.P. Muller, S. Huiss, and F. Schneider Secondary immune responses in parents of children with recent measles Lancet 348 1996 1379 1380
39. J. Mossong, D.J. Nokes, W.J. Edmunds, M.J. Cox, S. Ratnam, and C.P. Muller Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity Am J Epidemiol 150 1999 1238 1249